UM

Browse/Search Results:  1-10 of 42 Help

Selected(0)Clear Items/Page:    Sort:
Targeting B7-H3 via chimeric antigen receptor T cells and bispecific killer cell engagers augments antitumor response of cytotoxic lymphocytes Journal article
Journal of Hematology and Oncology, 2021,Volume: 14,Issue: 1
Authors:  Liu,Jie;  Yang,Shuo;  Cao,Bihui;  Zhou,Guangyu;  Zhang,Fengjuan;  Wang,Yuan;  Wang,Rixin;  Zhu,Lipeng;  Meng,Ya;  Hu,Cong;  Liang,Hui;  Lin,Xu;  Zhu,Kangshun;  Chen,Guokai;  Luo,Kathy Qian;  Di,Lijun;  Zhao,Qi
Favorite |  | TC[WOS]:1 TC[Scopus]:2 | Submit date:2021/03/04
B7-h3  Bike  Bispecific Antibody  Car t  Chimeric Antigen Receptor  Non-small Cell Lung Cancer  Pd-l1  
Combination therapy with PD-1/PD-L1 blockade in non-small cell lung cancer: strategies and mechanisms Journal article
Pharmacology and Therapeutics, 2021,Volume: 219
Authors:  Huang,Mu Yang;  Jiang,Xiao Ming;  Wang,Bing Lin;  Sun,Yang;  Lu,Jin Jian
Favorite |  | TC[WOS]:1 TC[Scopus]:2 | Submit date:2021/03/02
Challenge  Combination Therapy  Immunotherapy  Mechanism  Nsclc  Pd-1/pd-l1  
Discovery of a novel EGFR ligand DPBA that degrades EGFR and suppresses EGFR-positive NSCLC growth Journal article
Signal Transduction and Targeted Therapy, 2020,Volume: 5,Issue: 1
Authors:  Yao,Nan;  Wang,Chen Ran;  Liu,Ming Qun;  Li,Ying Jie;  Chen,Wei Min;  Li,Zheng Qiu;  Qi,Qi;  Lu,Jin Jian;  Fan,Chun Lin;  Chen,Min Feng;  Qi,Ming;  Li,Xiao Bo;  Hong,Jian;  Zhang,Dong Mei;  Ye,Wen Cai
Favorite |  | TC[WOS]:1 TC[Scopus]:1 | Submit date:2021/03/02
Genomic characteristics and drug screening among organoids derived from non-small cell lung cancer patients Journal article
Thoracic Cancer, 2020,Volume: 11,Issue: 8,Page: 2279-2290
Authors:  Chen,Jing Hua;  Chu,Xiang Peng;  Zhang,Jia Tao;  Nie,Qiang;  Tang,Wen Fang;  Su,Jian;  Yan,Hong Hong;  Zheng,Hong Ping;  Chen,Ze Xin;  Chen,Xin;  Song,Meng Meng;  Yi,Xin;  Li,Pan Song;  Guan,Yan Fang;  Li,Gang;  Deng,Chu Xia;  Rosell,Rafael;  Wu,Yi Long;  Zhong,Wen Zhao
Favorite |  | TC[WOS]:2 TC[Scopus]:2 | Submit date:2021/03/02
Consistency analysis  drug screening  non-small cell lung cancer  patient-derived organoid  whole exome sequencing  
Current strategies for treating NSCLC: From biological mechanisms to clinical treatment Journal article
Cancers, 2020,Volume: 12,Issue: 6,Page: 1-24
Authors:  Li,Junnan;  Kwok,Hang Fai
Favorite |  | TC[WOS]:5 TC[Scopus]:5 | Submit date:2021/03/04
Combination targeted therapy  Drug resistance mechanism  EGFR mutation  Lung cancer  
Phanginin R induces cytoprotective autophagy via JNK/C-JUN signaling pathway in non-small cell lung cancer A549 cells Journal article
Anti-Cancer Agents in Medicinal Chemistry, 2020,Volume: 20,Issue: 8,Page: 982-988
Authors:  Zhang,Le Le;  Bao,Han;  Xu,Yu Lian;  Jiang,Xiao Ming;  Li,Wei;  Zou,Liang;  Lin,Li Gen;  Lu,Jin Jian
Favorite |  | TC[WOS]:1 TC[Scopus]:2 | Submit date:2021/03/01
Anti-cancer  Autophagy  C-jun  Jnk  Non-small Cell Lung Cancer  Phanginin r  
B7-H3, a checkpoint molecule, as a target for cancer immunotherapy Journal article
International Journal of Biological Sciences, 2020,Volume: 16,Issue: 11,Page: 1767-1773
Authors:  Yang,Shuo;  Wei,Wei;  Zhao,Qi
Favorite |  | TC[WOS]:16 TC[Scopus]:19 | Submit date:2021/03/04
Antibody  B7-h3  Cancer Immunotherapy  Cd276  Immune Checkpoint  
Novel Therapeutic Anti-ADAM17 Antibody A9(B8) Enhances EGFR-TKI–Mediated Anticancer Activity in NSCLC Journal article
Translational Oncology, 2019,Volume: 12,Issue: 11,Page: 1516-1524
Authors:  Yang,Zheng;  Chan,Kin Iong;  Kwok,Hang Fai;  Tam,Kin Yip
Favorite |  | TC[WOS]:4 TC[Scopus]:3 | Submit date:2021/03/04
Upregulation of phosphoserine phosphatase contributes to tumor progression and predicts poor prognosis in non-small cell lung cancer patients Journal article
THORACIC CANCER, 2019,Volume: 10,Issue: 5,Page: 1203-1212
Authors:  Li Liao;  Huajian Yu;  Mengxi Ge;  Qiong Zhan;  Ruofan Huang;  Xiaoyu Ji;  Xiaohua Liang;  Xinli Zhou
Favorite |  | TC[WOS]:3 TC[Scopus]:3 | Submit date:2020/03/10
Akt/ampk Signaling Pathway  Metastasis  Nsclc  Proliferation  Psph  
Establishment and characterization of pemetrexed-resistant NCI-H460/PMT cells Journal article
Anti-Cancer Agents in Medicinal Chemistry, 2019,Volume: 19,Issue: 6,Page: 731-739
Authors:  Xu,Yu Lian;  Jiang,Xiao Ming;  Zhang,Le Le;  Chen,Xiuping;  Huang,Zhang Jian;  Lu,Jin Jian
Favorite |  | TC[WOS]:2 TC[Scopus]:2 | Submit date:2021/03/01
Abcb1  Chemotherapy  Nsclc  Pemetrexed  Resistance  Tyms